Deltorphin I

From WikiMD's Medical Encyclopedia

Revision as of 03:34, 13 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Deltorphin I[edit]

Chemical structure of Deltorphin I

Deltorphin I is a naturally occurring opioid peptide that is known for its high affinity and selectivity for the delta-opioid receptor. It is one of the most potent delta-opioid receptor agonists discovered in nature. Deltorphin I was originally isolated from the skin of frogs belonging to the genus Phyllomedusa, specifically Phyllomedusa bicolor.

Structure[edit]

Deltorphin I is a heptapeptide with the amino acid sequence Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2. The presence of D-amino acids in its structure is crucial for its high affinity and selectivity towards the delta-opioid receptor. The peptide's structure allows it to interact effectively with the receptor, leading to its potent analgesic effects.

Mechanism of Action[edit]

Deltorphin I exerts its effects by binding to the delta-opioid receptor, a type of G protein-coupled receptor (GPCR) found in the central nervous system. Upon binding, it activates the receptor, leading to a cascade of intracellular events that result in analgesia. The activation of delta-opioid receptors by Deltorphin I can modulate neurotransmitter release and influence pain perception.

Pharmacological Effects[edit]

The primary effect of Deltorphin I is analgesia, making it a subject of interest for pain management research. Unlike mu-opioid receptor agonists, delta-opioid receptor agonists like Deltorphin I may produce analgesia with a lower risk of addiction and respiratory depression. However, the clinical application of Deltorphin I is limited due to its peptide nature, which affects its stability and bioavailability.

Sources and Isolation[edit]

Deltorphin I was first isolated from the skin secretions of Phyllomedusa bicolor, a frog native to South America. The isolation of Deltorphin I and related peptides has provided insights into the diversity of bioactive compounds in amphibian skin and their potential therapeutic applications.

Research and Applications[edit]

Research on Deltorphin I focuses on its potential use in pain management and its role in understanding the delta-opioid receptor system. Studies aim to develop analogs with improved stability and bioavailability for potential therapeutic use. Additionally, Deltorphin I serves as a tool in pharmacological research to study the delta-opioid receptor and its physiological roles.

Related Pages[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.